![](https://xynomicpharma.com/wp-content/uploads/2017/02/2020slide4.png)
![](https://xynomicpharma.com/wp-content/uploads/2017/02/2022slide01-1.png)
![](https://xynomicpharma.com/wp-content/uploads/2017/02/2022slide05.png)
![](https://xynomicpharma.com/wp-content/uploads/2017/02/2022slide02.png)
![](https://xynomicpharma.com/wp-content/uploads/2017/02/2022slide04.png)
Dr. Bing Zhao, MD
Vice President of Clinical & Regulatory Affairs, Greater China
Dr. Zhao received his BS, MS, and MD (all majored in Oncology) from Xi’an Jiaotong University Health Science Center. He was a practicing oncologist in Xi’An, China from 1997-2007. In 2008 joined BMS in its clinical affairs department and since then has assumed increasing responsibilities as a clinical trial expert at Beijing H&J CRO International (Vice President and Director of Clinical Center), Shanghai Rundo CRO (Director of Clinical Center) ,3D-HTS (Vice President),Osmunda (Executive Vice General Manager and Director of Clinical Center)